Nomura Holdings’s Aerie Pharmaceuticals AERI Stock Holding History

Nomura Holdings’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-46,893	Closed	-$709K	–	1956
2022 Q3	$709K	Buy	+46,893	New	+$545K	﹤0.01%	1035
2020 Q1	–	Sell	-14,400	Closed	-$347K	–	1295
2019 Q4	$347K	Buy	+14,400	New	+$298K	﹤0.01%	956

Nomura Holdings's AERI Position: Q4 2022 in Review

Nomura Holdings sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 46,893 shares — an estimated $709K sold.

Nomura Holdings first reported a position in AERI in Q4 2019 and held it in 2 quarters. The position peaked at $709K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Nomura Holdings reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Nomura Holdings sold 46,893 Aerie Pharmaceuticals shares in Q4 2022, an estimated $709K.
Nomura Holdings first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 2 quarters.
Nomura Holdings's Aerie Pharmaceuticals position peaked at $709K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Nomura Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.